Document Detail


Unusual and early hyperglycemia following amiodarone infusion in two infants.
MedLine Citation:
PMID:  16132303     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Amiodarone is an effective antiarrhythmic agent that is widely used for tachyarrhythmias, especially ventricular tachycardia and supraventricular tachycardia. It has some mild short-term (e.g., skin rashes, gastrointestinal symptoms, and corneal microdeposits) and long-term side effects (thyroid dysfunction, visual disturbances, pulmonary infiltrates, ataxia, and hepatitis). We present two infants who had hyperglycemia following amiodarone infusion during the early postoperative period.
Authors:
S V Yildirim; E Azak; B Varan; K Tokel
Related Documents :
7473893 - Radiosensitization by dimethylbenzanthracene, diphenylcyclopropenone and aminoanthraqui...
7260553 - Surgical correction of torsion of the penis.
2209513 - Gastric emptying in infants with or without gastro-oesophageal reflux according to the ...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Pediatric cardiology     Volume:  26     ISSN:  0172-0643     ISO Abbreviation:  Pediatr Cardiol     Publication Date:    2005 Sep-Oct
Date Detail:
Created Date:  2005-12-26     Completed Date:  2006-03-28     Revised Date:  2008-02-20    
Medline Journal Info:
Nlm Unique ID:  8003849     Medline TA:  Pediatr Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  715-6     Citation Subset:  IM    
Affiliation:
Division of Pediatric Cardiology, Baskent University, Faculty of Medicine, Ankara, Turkey. svefay@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amiodarone / adverse effects*
Anti-Arrhythmia Agents / adverse effects*
Cardiac Surgical Procedures
Female
Heart Septal Defects, Ventricular / surgery
Humans
Hyperglycemia / chemically induced*
Infant
Infant, Newborn
Male
Tachycardia, Supraventricular / drug therapy,  etiology
Transposition of Great Vessels / surgery
Ventricular Fibrillation / drug therapy,  etiology
Chemical
Reg. No./Substance:
0/Anti-Arrhythmia Agents; 1951-25-3/Amiodarone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Real-time magnetic resonance imaging to guide pediatric endovascular procedures.
Next Document:  Captopril-induced pulmonary infiltrates with eosinophilia in an infant with congenital heart disease...